The fear of the second wave is upon markets - Tuesday review, May 12

The fear of the second wave is upon markets - Tuesday review, May 12

In anticipation of the decisions that will take place today, most markets performed negatively

The US

All major indices lost yesterday after Fauci’s statement regarding the treatment for the Coronavirus. He said that a treatment or a vaccine would probably be ready in late August or September. Until then, he fears of more cases and deaths as the economy is about to reopen. Moreover, investors expect the Fed’s decision regarding the negative interest rates. USA30 lost 1.89%, while USA500 shed 2.05%. TECH100 dropped 2.06%.

Oil lost 1.63% to $25.36 per barrel. Brent Oil fell 2.03% to $29.37 a barrel.

Gold gained 0.07% to trade at $1,705.65 per ounce.

ICE lost 0.32% to be at 99.950.


Asia and Australia

Loses also continued on the other side of the ocean: Japan225 lost 0.8%. Australia’s ASX went down by 1%.

USD/JPY traded at 107.15 after it dropped from 107.76 – the highest it has been since April 24.

AUD/USD traded lower than it did on Monday, at $0.6473.


Europe

In Europe, markets were mixed, the only benchmarks which gained were Europe50 and UK100. The first rose 0.3%, while the latter added 0.9%. Germany30 lost 0.05%.

EUR/USD was at $1.0848.

EUR/GBP gained 0.92% to 0.8837.

GBP/USD was close to a five-week low at $1.2264, as the government doesn’t seem to reach a viable decision regarding the lockdown measures.

See the difference when trading with CAPEX.com by accessing elite features:

  • Stellar custom service
  • Powerful WebTrader platform and mobile app
  • High-end integrated trading tools
  • Full license and regulation from top regulators


Sources: reuters.com, investing.com, marketwatch.com


The information presented herein is prepared by CAPEX.com and does not intend to constitute Investment Advice. The information herein is provided as a general marketing communication for information purposes only and as such it has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and it is not subject to any prohibition on dealing ahead of the dissemination of investment research.

Users/readers should not rely solely on the information presented herewith and should do their own research/analysis by also reading the actual underlying research. The content herewith is generic and does not take into consideration individual personal circumstances, investment experience or current financial situation.

Therefore, Key Way Investments Ltd shall not accept any responsibility for any losses of traders due to the use and the content of the information presented herein. Past performance is not a reliable indicator of future results.